Skip to main content
Premium Trial:

Request an Annual Quote

Waters to Supply GeneProt s NJ Facility with $10 Million in Mass Spec Instruments and Services

NEW YORK, Dec. 3 — Gene Prot and Waters announced Monday an agreement to equip GeneProt’s new industrial-scale proteomics facility.

Waters, through its subsidiary Micromass UK, will buy a maximum of $10 million of equity securities in GeneProt. The proteomics company will in turn purchase from Micromass about $20 million in mass spectrometry machines and services. The two companies will also collaborate on product development for these instruments.

GeneProt announced in October that it was building a 100,000 square foot, 150-person proteomics facility in North Brunswick, NJ. Scheduled to be fully operational in the second quarter of 2002, the new protein sequencing and analysis center will double the company’s capacity. GeneProt says it will be the largest proteomics center in the US.

Micromass will supply a total of 45 new Micromass Q-Tof instruments to the center, 40 of which are advanced integrated Micromass CapLC Q-Tof Micro systems. They are slated to be installed by mid-2002. Although it is primarily equipped with Micromass technology, the North Brunswick center will also include six new Bruker Daltonics MALDI-TOF/TOF machines.

In September 2000, GeneProt struck a similar deal with Bruker to equip its Geneva facility. Under that arrangement, GeneProt installed 51 Bruker machines — 45 ion trap and six MALDI-TOF instruments — in exchange for an undisclosed equity investment, stocking its new Swiss proteomics facility exclusively with Bruker instruments.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.